More treatments for SARS-CoV-2 are urgently needed. Emergency Use Authorization is a necessary tool that can be used to make promising interventions available to those infected, treat patients earlier in the disease, and avert hospitalizations. Shifting the attention from inpatient to outpatient management of COVID-19 requires transparency in clinical efficacy, widespread equitable distribution of novel therapeutics, and controls on cost.
That sounds to me like she’s of the opinion that Emergency Use Authorization was given out to freely under the Trump administration and should come with more regulation for transparency, equity and cost control.
In a she coauthered they write:
That sounds to me like she’s of the opinion that Emergency Use Authorization was given out to freely under the Trump administration and should come with more regulation for transparency, equity and cost control.